Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$6.89 - $11.04 $6,483 - $10,388
-941 Reduced 68.64%
430 $3,000
Q2 2023

Aug 10, 2023

BUY
$13.68 - $16.56 $5,595 - $6,773
409 Added 42.52%
1,371 $18,000
Q1 2023

May 15, 2023

SELL
$15.9 - $22.22 $5,247 - $7,332
-330 Reduced 25.54%
962 $15,000
Q4 2022

Jun 14, 2023

BUY
$17.16 - $22.14 $5,662 - $7,306
330 Added 34.3%
1,292 $22.9 Million
Q3 2022

Jun 14, 2023

BUY
$19.35 - $23.52 $6,385 - $7,761
330 Added 34.3%
1,292 $25.2 Million
Q2 2022

Jun 20, 2023

BUY
$19.9 - $26.13 $6,566 - $8,622
330 Added 34.3%
1,292 $25,000
Q1 2022

Jun 20, 2023

BUY
$23.62 - $29.18 $7,794 - $9,629
330 Added 34.3%
1,292 $33,000
Q1 2022

Mar 30, 2023

SELL
$23.62 - $29.18 $92,826 - $114,677
-3,930 Reduced 75.26%
1,292 $33,000
Q1 2022

May 12, 2022

SELL
$23.62 - $29.18 $92,826 - $114,677
-3,930 Reduced 75.26%
1,292 $33,000
Q4 2021

Jun 21, 2023

BUY
$25.26 - $32.0 $107,607 - $136,320
4,260 Added 442.83%
5,222 $131,000
Q4 2021

Mar 30, 2023

BUY
$25.26 - $32.0 $21,647 - $27,424
857 Added 19.63%
5,222 $131,000
Q4 2021

Feb 15, 2022

BUY
$25.26 - $32.0 $21,647 - $27,424
857 Added 19.63%
5,222 $132,000
Q3 2021

Jun 21, 2023

BUY
$26.5 - $34.0 $90,179 - $115,702
3,403 Added 353.74%
4,365 $117,000
Q3 2021

Mar 30, 2023

SELL
$26.5 - $34.0 $41,313 - $53,006
-1,559 Reduced 26.32%
4,365 $117,000
Q3 2021

Nov 15, 2021

SELL
$26.5 - $34.0 $41,313 - $53,006
-1,559 Reduced 26.32%
4,365 $117,000
Q2 2021

Jun 21, 2023

BUY
$27.73 - $46.06 $137,596 - $228,549
4,962 Added 515.8%
5,924 $188,000
Q2 2021

Mar 30, 2023

BUY
$27.73 - $46.06 $859 - $1,427
31 Added 0.53%
5,924 $188,000
Q2 2021

Aug 16, 2021

BUY
$27.73 - $46.06 $164,106 - $272,583
5,918 Added 98633.33%
5,924 $189,000
Q1 2021

Jun 26, 2023

BUY
$29.77 - $51.8 $146,795 - $255,425
4,931 Added 512.58%
5,893 $207 Million
Q1 2021

May 14, 2021

SELL
$29.77 - $51.8 $175,255 - $304,946
-5,887 Reduced 99.9%
6 $207,000
Q4 2020

Jun 22, 2023

BUY
$28.96 - $33.77 $142,801 - $166,519
4,931 Added 512.58%
5,893 $188,000
Q3 2020

Jun 26, 2023

BUY
$29.0 - $41.83 $142,999 - $206,263
4,931 Added 512.58%
5,893 $186,000
Q3 2020

Mar 30, 2023

SELL
$29.0 - $41.83 $8,874 - $12,799
-306 Reduced 4.94%
5,893 $186,000
Q3 2020

Nov 13, 2020

SELL
$29.0 - $41.83 $8,874 - $12,799
-306 Reduced 4.94%
5,893 $186,000
Q2 2020

Jun 26, 2023

BUY
$27.94 - $40.96 $146,321 - $214,507
5,237 Added 544.39%
6,199 $220,000
Q1 2020

Jul 12, 2023

BUY
$22.18 - $28.78 $116,156 - $150,720
5,237 Added 544.39%
6,199 $178,000
Q4 2019

Jul 12, 2023

BUY
$17.87 - $27.37 $93,585 - $143,336
5,237 Added 544.39%
6,199 $145,000
Q3 2019

Jul 12, 2023

BUY
$15.01 - $18.47 $78,607 - $96,727
5,237 Added 544.39%
6,199 $111,000
Q2 2019

Jul 12, 2023

BUY
$15.32 - $23.65 $80,230 - $123,855
5,237 Added 544.39%
6,199 $97,000
Q1 2019

Jul 13, 2023

BUY
$20.5 - $24.32 $107,358 - $127,363
5,237 Added 544.39%
6,199 $141,000
Q1 2019

Mar 30, 2023

BUY
$20.5 - $24.32 $100,593 - $119,338
4,907 Added 379.8%
6,199 $141,000
Q1 2019

May 16, 2019

SELL
$20.5 - $24.32 $402,353 - $477,328
-19,627 Reduced 76.0%
6,199 $141,000
Q1 2019

May 15, 2019

BUY
$20.5 - $24.32 $402,353 - $477,328
19,627 Added 316.62%
25,826 $814,000
Q4 2018

Jul 13, 2023

BUY
$22.42 - $32.67 $117,413 - $171,092
5,237 Added 544.39%
6,199 $144,000
Q4 2018

Feb 14, 2019

BUY
$22.42 - $32.67 $107,100 - $156,064
4,777 Added 335.94%
6,199 $144,000
Q3 2018

Jul 13, 2023

BUY
$33.01 - $44.57 $172,873 - $233,413
5,237 Added 544.39%
6,199 $205 Million
Q3 2018

Nov 14, 2018

SELL
$33.01 - $44.57 $157,688 - $212,910
-4,777 Reduced 77.06%
1,422 $47,000
Q4 2017

Feb 15, 2018

SELL
$34.19 - $48.11 $264,801 - $372,611
-7,745 Reduced 55.54%
6,199 $282,000
Q3 2017

Nov 14, 2017

SELL
$33.15 - $48.95 $11,635 - $17,181
-351 Reduced 2.46%
13,944 $462,000
Q2 2017

Aug 14, 2017

BUY
N/A
14,295
14,295 $580,000

Others Institutions Holding PETS

About PETMED EXPRESS INC


  • Ticker PETS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 21,013,800
  • Market Cap $102M
  • Description
  • PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...
More about PETS
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.